Test your knowledge of the newly updated obesity algorithm from the Obesity Medicine Association with this 8-question challenge.
The Obesity Medicine Association (OMA) recently released the 2018 updates to The Obesity Algorithm® for pediatric and adult patients. How much do you know about obesity trends, categories, and treatments? Find out with our 8-question quiz below.
Question 1.
Please click here for answer and next question.
Answer: B. False. Between 2015 and 2016, the prevalence of obesity was higher among US adults (40%) vs youth (18.5%).
Question 2.
Please click here for answer and next question.
Answer: D. 35-39.9. A BMI between 18.5-24.9 kg/m2 is classified as normal, 25.0-29.9 kg/m2 is classified as overweight, 30.0-34.9 kg/m2 is classified as class I obesity, 35-39.9 kg/m2 is classified as class II obesity, and ≥40 kg/m2 is classified as class III obesity.
Question 3.
Please click here for answer and next question.
Answer: D. 32%. In women, a body fat percentage of ≥32% is classified as overweight or obese.
Question 4.
Please click here for answer and next question.
Answer: B. False. DXA measures fat mass and lean soft tissue mass OR soft tissue mass and bone mineral mass, but not fat mass and soft tissue mass.
Question 5.
Please click here for answer and next question.
Answer: E. B and D. The prevalence of obesity was highest among non-Hispanic black and Hispanic adults vs non-Hispanic white and non-Hispanic Asian adults.
Question 6.
Please click here for answer and next question.
Answer: C. Orlistat. While orlistat (Alli, Xenical) is an FDA-approved anti-obesity drug, it was approved in 1999. Phentermine HCL/topiramate extended release (Qsymia) and lorcaserin (Belviq) were first approved in 2012 and liraglutide (Saxenda) was first approved in 2014.
Question 7.
Please click here for answer and next question.
Answer: A. <5000. <5000 steps taken per day is considered sedentary and this is the national average for US adults.
Question 8.
Answer: A. True. The OMA recommends that patients walk 10 minutes for every hour they have been sitting.
For more information, please visit www.obesityalgorithm.org.
3 Reasons Urology Practices Should Add Onsite UTI PCR Labs Under New LCD Rules
March 11th 20251. ONSITE PCR TESTING BRINGS SIGNIFICANT CLINICAL BENEFITS TO A PRACTICE. - ACCURACY Traditional urine cultures can give false-negative results. - SPECIFICITY Accurate microbial identification leads to targeted treatment. - SPEED Same day results vs. 3-5 days for traditional urine cultures - - - ANTIBIOTIC RESISTANCE MARKERS Improves antimicrobial stewardship 2. MAINTAIN INDEPENDENCE BY INCREASING REVENUE SIGNIFICANTLY THROUGH REVENUE SHIFTING FROM THE REFERENCE LAB TO THE PRACTICE. - Turnkey: Consultation on COLA and CLIA certification, all necessary equipment, standard operating procedures, personnel sourcing and interview, billing and coding training, 3-4 days of onsite training. - Stark Law Compliant: Complies with anti-kickback statutes. - Medicare part B pays at 100%, Med Advantage Plans at 80% - No lab build-out, only 8 linear feet of counter space needed - Z-code procurement for required states 3. BETTER PATIENT CARE LEADS TO BETTER OUTCOMES. - CONVENIENCE Point of care, no third-party referral lab. - TIMELY Results early in the care process. - CORRECT MEDICATION Avoids two trips to the pharmacy. - BETTER OUTCOMES Reduction of recurrent UTI and hospitalizations